Koa Shoji Holdings Co.,Ltd. (9273.T)
JPY 611.0
(2.0%)
JPY 611.0
(2.0%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 6.95 Billion JPY | -7.81% |
| 2022 | 7.54 Billion JPY | -0.57% |
| 2021 | 7.58 Billion JPY | -6.38% |
| 2020 | 8.1 Billion JPY | 1.43% |
| 2019 | 7.98 Billion JPY | -7.98% |
| 2018 | 8.67 Billion JPY | 0.83% |
| 2017 | 8.6 Billion JPY | 17.82% |
| 2016 | 7.3 Billion JPY | 35.17% |
| 2015 | 5.4 Billion JPY | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q1 | 7.44 Billion JPY | -1.3% |
| 2023 FY | 6.95 Billion JPY | -7.81% |
| 2023 Q2 | 7.65 Billion JPY | 2.88% |
| 2023 Q4 | 6.95 Billion JPY | -4.5% |
| 2023 Q3 | 7.28 Billion JPY | -4.92% |
| 2022 Q3 | 7.24 Billion JPY | -10.18% |
| 2022 Q2 | 8.06 Billion JPY | 8.81% |
| 2022 Q1 | 7.41 Billion JPY | -2.23% |
| 2022 FY | 7.54 Billion JPY | -0.57% |
| 2022 Q4 | 7.54 Billion JPY | 4.06% |
| 2021 Q3 | 7.07 Billion JPY | -11.74% |
| 2021 FY | 7.58 Billion JPY | -6.38% |
| 2021 Q1 | 7.69 Billion JPY | -5.02% |
| 2021 Q4 | 7.58 Billion JPY | 7.26% |
| 2021 Q2 | 8.01 Billion JPY | 4.11% |
| 2020 Q2 | 7.8 Billion JPY | 9.23% |
| 2020 FY | 8.1 Billion JPY | 1.43% |
| 2020 Q1 | 7.14 Billion JPY | -10.53% |
| 2020 Q4 | 8.1 Billion JPY | 7.28% |
| 2020 Q3 | 7.55 Billion JPY | -3.26% |
| 2019 Q3 | 7.64 Billion JPY | 0.05% |
| 2019 FY | 7.98 Billion JPY | -7.98% |
| 2019 Q1 | 7.07 Billion JPY | -18.54% |
| 2019 Q2 | 7.64 Billion JPY | 8.13% |
| 2019 Q4 | 7.98 Billion JPY | 4.42% |
| 2018 Q2 | 7.95 Billion JPY | 1.39% |
| 2018 FY | 8.67 Billion JPY | 0.83% |
| 2018 Q4 | 8.67 Billion JPY | 9.35% |
| 2018 Q3 | 7.93 Billion JPY | -0.22% |
| 2018 Q1 | 7.84 Billion JPY | -8.86% |
| 2017 Q3 | 8.21 Billion JPY | 0.0% |
| 2017 FY | 8.6 Billion JPY | 17.82% |
| 2017 Q4 | 8.6 Billion JPY | 4.75% |
| 2016 FY | 7.3 Billion JPY | 35.17% |
| 2015 FY | 5.4 Billion JPY | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 24.98 Billion JPY | 72.177% |
| Takeda Pharmaceutical Company Limited | 7834.78 Billion JPY | 99.911% |
| Sumitomo Pharma Co., Ltd. | 751.37 Billion JPY | 99.075% |
| Shionogi & Co., Ltd. | 164.35 Billion JPY | 95.77% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.39 Billion JPY | -104.783% |
| Nippon Shinyaku Co., Ltd. | 42.86 Billion JPY | 83.782% |
| Kaken Pharmaceutical Co., Ltd. | 27.86 Billion JPY | 75.051% |
| Eisai Co., Ltd. | 494.82 Billion JPY | 98.595% |
| Morishita Jintan Co., Ltd. | 5.04 Billion JPY | -37.943% |
| Hisamitsu Pharmaceutical Co., Inc. | 61.69 Billion JPY | 88.731% |
| Mochida Pharmaceutical Co., Ltd. | 30.83 Billion JPY | 77.451% |
| Fuso Pharmaceutical Industries,Ltd. | 39.79 Billion JPY | 82.529% |
| Nippon Chemiphar Co., Ltd. | 31.08 Billion JPY | 77.634% |
| Tsumura & Co. | 132.88 Billion JPY | 94.768% |
| Kissei Pharmaceutical Co., Ltd. | 39.79 Billion JPY | 82.528% |
| Torii Pharmaceutical Co., Ltd. | 13.29 Billion JPY | 47.715% |
| Towa Pharmaceutical Co., Ltd. | 274.75 Billion JPY | 97.47% |
| Fuji Pharma Co., Ltd. | 44.15 Billion JPY | 84.256% |
| Zeria Pharmaceutical Co., Ltd. | 70.7 Billion JPY | 90.167% |
| KYORIN Holdings, Inc. | 46.89 Billion JPY | 85.174% |
| Taiko Pharmaceutical Co.,Ltd. | 7 Billion JPY | 0.723% |
| Daito Pharmaceutical Co.,Ltd. | 25.43 Billion JPY | 72.671% |
| SymBio Pharmaceuticals Limited | 8.14 Billion JPY | 14.613% |
| MedRx Co., Ltd | 129 Million JPY | -5289.41% |
| Mizuho Medy Co.,Ltd. | 3.27 Billion JPY | -112.445% |
| Solasia Pharma K.K. | 673 Million JPY | -933.037% |
| Modalis Therapeutics Corporation | 645.5 Million JPY | -977.042% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 31.38 Billion JPY | 77.845% |
| Sawai Group Holdings Co., Ltd. | 163.99 Billion JPY | 95.761% |
| Cyfuse Biomedical K.K. | 1.01 Billion JPY | -587.438% |
| Toho Holdings Co., Ltd. | 523.98 Billion JPY | 98.673% |